refine.bio
  • Search
      • Normalized Compendia
      • RNA-seq Sample Compendia
  • Docs
  • About
  • My Dataset
github link
Showing
of 12268 results
Sort by

Filters

Technology

Platform

accession-icon GSE60408
Expression profiles in 3 different B-cell lymphoma cell lines treated by 92 FDA approved compounds
  • organism-icon Homo sapiens
  • sample-icon 863 Downloadable Samples
  • Technology Badge Icon Affymetrix Human Genome U219 Array (hgu219)

Description

Identifying the Mechanism of Action (MoA) of drugs is critical for the development of new drugs, understanding their side effects, and drug repositioning. However, identifying drug MoA has been challenging and has been traditionally attempted only though large experimental setups with little success. While advances in computational power offers the opportunity to achieve this in-silico, methods to exploit existing computational resources are still in their infancy. To overcome this, we developed a novel method to identify Drug Mechanism of Action using Network Dysregulation (DeMAND).

Publication Title

Elucidating Compound Mechanism of Action by Network Perturbation Analysis.

Sample Metadata Fields

Cell line, Time

View Samples
accession-icon GSE2350
Normal and transformed human mature B cells
  • organism-icon Homo sapiens
  • sample-icon 344 Downloadable Samples
  • Technology Badge Icon Affymetrix Human Genome U95A Array (hgu95a)

Description

Phenotypes representative of normal, transformed and experimentally manipulated human B cells related to the germinal center structure.

Publication Title

Reverse engineering of regulatory networks in human B cells.

Sample Metadata Fields

Specimen part

View Samples
accession-icon GSE30483
Tissue-specific genetic regulation of splicing and expression
  • organism-icon Homo sapiens
  • sample-icon 343 Downloadable Samples
  • Technology Badge Icon Affymetrix Human Exon 1.0 ST Array [transcript (gene) version (huex10st)

Description

This SuperSeries is composed of the SubSeries listed below.

Publication Title

Tissue-specific genetic control of splicing: implications for the study of complex traits.

Sample Metadata Fields

Sex, Age

View Samples
accession-icon GSE16134
Bacterial Correlates of Gingival Gene Expression
  • organism-icon Homo sapiens
  • sample-icon 307 Downloadable Samples
  • Technology Badge Icon Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Description

We investigated the association between subgingival bacterial profiles and gene expression patterns in gingival tissues of patients with periodontitis.

Publication Title

Subgingival bacterial colonization profiles correlate with gingival tissue gene expression.

Sample Metadata Fields

Specimen part

View Samples
accession-icon GSE51068
High-throughput expression profiling of OCI-Ly3 cell line upon treatment with a panel of 14 known drugs.
  • organism-icon Homo sapiens
  • sample-icon 282 Downloadable Samples
  • Technology Badge Icon Affymetrix Human Genome U219 Array (hgu219)

Description

Analysis of Diffuse Large B-Cell Lymphoma (DLBCL) OCI-LY3 cell line treated with 14 different known drugs at 2 different concentrations and profiled at 6, 12 and 24 hrs after treatment.

Publication Title

A community computational challenge to predict the activity of pairs of compounds.

Sample Metadata Fields

Compound, Time

View Samples
accession-icon GSE10334
Transcriptomes in Healthy and Diseased Gingival Tissues
  • organism-icon Homo sapiens
  • sample-icon 242 Downloadable Samples
  • Technology Badge Icon Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Description

We examined gene expression signatures in healthy and diseased gingival tissues in 90 patients. Analysis of the gingival tissue transcriptome in states of periodontal health and disease may reveal novel insights of the pathobiology of periodontitis.

Publication Title

Transcriptomes in healthy and diseased gingival tissues.

Sample Metadata Fields

Specimen part

View Samples
accession-icon GSE30422
Tissue-specific genetic regulation of splicing and expression (exon-level)
  • organism-icon Homo sapiens
  • sample-icon 172 Downloadable Samples
  • Technology Badge Icon Affymetrix Human Exon 1.0 ST Array [transcript (gene) version (huex10st)

Description

Numerous genome-wide screens for polymorphisms that influence gene expression have provided key insights into the genetic control of transcription. Despite this work, the relevance of specific polymorphisms to in vivo expression and splicing remains unclear. We carried out the first genome-wide screen, to our knowledge, for SNPs that associate with alternative splicing and gene expression in human primary cells, evaluating 93 autopsy-collected cortical brain tissue samples with no defined neuropsychiatric condition and 80 peripheral blood mononucleated cell samples collected from living healthy donors. We identified 23 high confidence associations with total expression and 80 with alternative splicing as reflected by expression levels of specific exons. Fewer than 50% of the implicated SNPs however show effects in both tissue types, reflecting strong evidence for distinct genetic control of splicing and expression in the two tissue types. The data generated here also suggest the possibility that splicing effects may be responsible for up to 13 out of 84 reported genome-wide significant associations with human traits. These results emphasize the importance of establishing a database of polymorphisms affecting splicing and expression in primary tissue types and suggest that splicing effects may be of more phenotypic significance than overall gene expression changes.

Publication Title

Tissue-specific genetic control of splicing: implications for the study of complex traits.

Sample Metadata Fields

Sex, Age

View Samples
accession-icon GSE30453
Tissue-specific genetic regulation of splicing and expression (gene-level)
  • organism-icon Homo sapiens
  • sample-icon 171 Downloadable Samples
  • Technology Badge Icon Affymetrix Human Exon 1.0 ST Array [transcript (gene) version (huex10st)

Description

Numerous genome-wide screens for polymorphisms that influence gene expression have provided key insights into the genetic control of transcription. Despite this work, the relevance of specific polymorphisms to in vivo expression and splicing remains unclear. We carried out the first genome-wide screen, to our knowledge, for SNPs that associate with alternative splicing and gene expression in human primary cells, evaluating 93 autopsy-collected cortical brain tissue samples with no defined neuropsychiatric condition and 80 peripheral blood mononucleated cell samples collected from living healthy donors. We identified 23 high confidence associations with total expression and 80 with alternative splicing as reflected by expression levels of specific exons. Fewer than 50% of the implicated SNPs however show effects in both tissue types, reflecting strong evidence for distinct genetic control of splicing and expression in the two tissue types. The data generated here also suggest the possibility that splicing effects may be responsible for up to 13 out of 84 reported genome-wide significant associations with human traits. These results emphasize the importance of establishing a database of polymorphisms affecting splicing and expression in primary tissue types and suggest that splicing effects may be of more phenotypic significance than overall gene expression changes.

Publication Title

Tissue-specific genetic control of splicing: implications for the study of complex traits.

Sample Metadata Fields

Sex, Age

View Samples
accession-icon GSE12195
Mutations of multiple genes deregulate the NF-kB pathway in diffuse large B cell lymphoma
  • organism-icon Homo sapiens
  • sample-icon 135 Downloadable Samples
  • Technology Badge Icon Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Description

Diffuse large B-cell lymphoma (DLBCL), the most common form of lymphoma in adulthood, comprises multiple biologically and clinically distinct subtypes including germinal center B cell-like (GCB) and activated B cell like (ABC) DLBCL. Gene expression profile studies have shown that its most aggressive subtype, ABC-DLBCL, is associated with constitutive activation of the NF-kB transcription complex. However, except for a small fraction of cases, it remains unclear whether NF-kB activation in these tumors represents an intrinsic program of the tumor cell of origin or a pathogenetic event. Here we show that >50% of ABC-DLBCL and a smaller fraction of GCB-DLBCL carry somatic mutations at multiple genes, including negative (TNFAIP3/A20) and positive (CARD11, TRAF2, TRAF5, MAP3K7/TAK1 and TNFRSF11A/RANK) regulators of NF-kB. Of these, the A20 gene, which encodes for a ubiquitin-modifying enzyme involved in termination of NF-kB responses, is the most commonly affected one, with ~30% of the patients displaying biallelic inactivation by mutations and/or deletions, suggesting a tumor suppressor role. Less frequently, missense mutations of TRAF2 and CARD11 produce molecules with significantly enhanced ability to activate NF-kB. Thus, our results demonstrate that NF-kB activation in DLBCL is caused by genetic lesions affecting multiple genes, whose loss or activation may promote lymphomagenesis by leading to abnormally prolonged NF-kB responses.

Publication Title

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

Sample Metadata Fields

Specimen part, Cell line

View Samples
accession-icon GSE68801
Human Alopecia Areata Skin Biopsy Samples
  • organism-icon Homo sapiens
  • sample-icon 116 Downloadable Samples
  • Technology Badge Icon Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Description

Gene expression profiling of scalp skin biopsies from patients with alopecia areata or normal healthy controls

Publication Title

Molecular signatures define alopecia areata subtypes and transcriptional biomarkers.

Sample Metadata Fields

Sex, Age, Disease, Subject

View Samples
...

refine.bio is a repository of uniformly processed and normalized, ready-to-use transcriptome data from publicly available sources. refine.bio is a project of the Childhood Cancer Data Lab (CCDL)

fund-icon Fund the CCDL

Developed by the Childhood Cancer Data Lab

Powered by Alex's Lemonade Stand Foundation

Cite refine.bio

Casey S. Greene, Dongbo Hu, Richard W. W. Jones, Stephanie Liu, David S. Mejia, Rob Patro, Stephen R. Piccolo, Ariel Rodriguez Romero, Hirak Sarkar, Candace L. Savonen, Jaclyn N. Taroni, William E. Vauclain, Deepashree Venkatesh Prasad, Kurt G. Wheeler. refine.bio: a resource of uniformly processed publicly available gene expression datasets.
URL: https://www.refine.bio

Note that the contributor list is in alphabetical order as we prepare a manuscript for submission.

BSD 3-Clause LicensePrivacyTerms of UseContact